|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2000; 35:1827-1834 © 2000 by the American College of Cardiology Foundation |
a Department of Internal Medicine, Division of Cardiology, University of Texas Medical Branch at Galveston, Texas, USA
Manuscript received August 26, 1999; revised manuscript received December 13, 1999, accepted February 9, 2000.
Reprint requests and correspondence: Dr. Christopher deFilippi, Cardiology Division, Room G3K63, Gudelsky Tower, University of Maryland Medical Center, 22 South Greene Street, Baltimore, Maryland 21201-1595.
cdefilip{at}medicine.umaryland.edu
OBJECTIVES
We prospectively evaluated the relation between cardiac troponin T (cTnT) level, the presence and severity of coronary artery disease (CAD) and long-term prognosis in patients with chest pain but no ischemic electrocardiographic (ECG) changes who had short-term observation.
BACKGROUND
Cardiac TnT is a powerful predictor of future myocardial infarction (MI) and death in patients with ECG evidence of an acute coronary syndrome. However, for patients with chest pain with normal ECGs, it has not been determined whether cTnT elevation is predictive of CAD and a poor long-term prognosis.
METHODS
In 414 consecutive patients with no ischemic ECG changes who were triaged to a chest pain unit, cTnT and creatine kinase, MB fraction (CK-MB) were evaluated 
10 h after symptom onset. Patients with adverse cardiac events, including death, MI, unstable angina and heart failure were followed for as long as one year.
RESULTS
A positive (>0.1 ng/ml) cTnT test was detected in 37 patients (8.9%). Coronary artery disease was found in 90% of 30 cTnT-positive patients versus 23% of 144 cTnT-negative patients who underwent angiography (p < 0.001), with multivessel disease in 63% versus 13% (p < 0.001). The cTnT-positive patients had a significantly (p < 0.05) higher percent diameter stenosis and a greater frequency of calcified, complex and occlusive lesions. Follow-up was available in 405 patients (98%). By one year, 59 patients (14.6%) had adverse cardiac events. The cumulative adverse event rate was 32.4% in cTnT-positive patients versus 12.8% in cTnT-negative patients (p = 0.001). After adjustment for baseline clinical characteristics, positive cTnT was a stronger predictor of events (chi-square = 23.56, p = 0.0003) than positive CK-MB (>5 ng/ml) (chi-square = 21.08, p = 0.0008). In a model including both biochemical markers, CK-MB added no predictive information as compared with cTnT alone (chi-square = 23.57, p = 0.0006).
CONCLUSIONS
In a group of patients with chest pain anticipated to have a low prevalence of CAD and a good prognosis, cTnT identifies a subgroup with a high prevalence of extensive and complex CAD and increased risk for long-term adverse outcomes.
| ||||||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  A. Jeremias, N. S. Kleiman, D. Nassif, W.-H. Hsieh, M. Pencina, K. Maresh, M. Parikh, D. E. Cutlip, R. Waksman, S. Goldberg, et al. Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results From the Evaluation of Drug Eluting Stents and Ischemic Events Registry Circulation, August 5, 2008; 118(6): 632 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bagwe, R. Sachdeva, and J. L. Mehta High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand? Eur. Heart J., May 1, 2007; 28(9): 1043 - 1044. [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Jaffe, L. Babuin, and F. S. Apple Biomarkers in Acute Cardiac Disease: The Present and the Future J. Am. Coll. Cardiol., July 4, 2006; 48(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Babuin and A. S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dokainish, M. Pillai, S. A. Murphy, P. M. DiBattiste, M. J. Schweiger, A. Lotfi, D. A. Morrow, C. P. Cannon, E. Braunwald, N. Lakkis, et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: A TACTICS-TIMI-18 substudy J. Am. Coll. Cardiol., January 4, 2005; 45(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death Clin. Chem., December 1, 2004; 50(12): 2279 - 2285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. deFilippi, S. Wasserman, S. Rosanio, E. Tiblier, H. Sperger, M. Tocchi, R. Christenson, B. Uretsky, M. Smiley, J. Gold, et al. Cardiac Troponin T and C-Reactive Protein for Predicting Prognosis, Coronary Atherosclerosis, and Cardiomyopathy in Patients Undergoing Long-term Hemodialysis JAMA, July 16, 2003; 290(3): 353 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kizer, M. R. Muttrej, W. H. Matthai, J. McConnell, H. Nardone, A. F. Sonel, M. G. Keane, and R. L. Wilensky Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur. Heart J., July 2, 2003; 24(14): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bholasingh, J. H. Cornel, O. Kamp, J. P. van Straalen, G. T. Sanders, J. G. P. Tijssen, V. A. W. M. Umans, C. A. Visser, and R. J. de Winter Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T J. Am. Coll. Cardiol., February 19, 2003; 41(4): 596 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kaul, L. K. Newby, Y. Fu, V. Hasselblad, K. W. Mahaffey, R. H. Christenson, R. A. Harrington, E. M. Ohman, E. J. Topol, R. M. Califf, et al. Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients J. Am. Coll. Cardiol., February 5, 2003; 41(3): 371 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease Circulation, December 3, 2002; 106(23): 2941 - 2945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Wong, D. A. Morrow, S. Murphy, N. Kraimer, R. Pai, D. James, D. H. Robertson, L. A. Demopoulos, P. DiBattiste, C. P. Cannon, et al. Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy Circulation, July 9, 2002; 106(2): 202 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.M. Antman, R. Corbalan, K. Huber, and A.S. Jaffe Issues in early risk stratification for UA/NSTEMI Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J6 - J14. [Abstract] [PDF]
|
|
|
|
|
|
L. K. Newby, E. M. Ohman, R. H. Christenson, D. J. Moliterno, R. A. Harrington, H. D. White, P. W. Armstrong, F. Van de Werf, M. Pfisterer, V. Hasselblad, et al. Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T-Positive Status : The PARAGON-B Troponin T Substudy Circulation, June 19, 2001; 103(24): 2891 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. deFilippi, S. Rosanio, M. Tocchi, R. J. Parmar, M. A. Potter, B. F. Uretsky, and M. S. Runge Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2042 - 2049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.W. Hamm GP IIb/IIIa receptor antagonists in unstable angina: troponin level-based patient selection Eur. Heart J. Suppl., May 1, 2001; 3(suppl_A): A14 - A20. [Abstract] [PDF]
|
|
|
|
|
|
L. K. Newby, A. B. Storrow, W. B. Gibler, J. L. Garvey, J. F. Tucker, A. L. Kaplan, D. H. Schreiber, R. H. Tuttle, S. E. McNulty, and E. M. Ohman Bedside Multimarker Testing for Risk Stratification in Chest Pain Units : The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study Circulation, April 10, 2001; 103(14): 1832 - 1837. [Abstract] [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
